Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

152 recalls · Class III, newest first

Class III · Low risk

Testosterone Topical Solution

Defective Container: Repetitive complaints received indicating pump not working.

Terminated Packaging defect Lupin Pharmaceuticals Inc. NDC 68180-943-11 D-1010-2019
Class III · Low risk

Mirapex (pramipexole dihydrochloride)

Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.

Terminated Failed specification Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0190-61 D-0991-2019
Class III · Low risk

ATHLETICARE Anti-Bacterial Hand Soap AC 550

Does Not Meet Monograph: product contains, triclosan, an ingredient that can no longer be contained in over-the-counter consumer antiseptic/antibacterial wash products.

Terminated Unapproved drug Petra Hygienic Systems Int Ltd NDC 42326-550-01 D-0994-2019
Class III · Low risk

Moxifloxacin Ophthalmic Solution USP

Failed Impurities/Degradation Specifications: Expansion of July 2018 and February 2019 recall due to high out-of-specification for impurities.

Terminated Impurity / degradation Lupin Pharmaceuticals Inc. NDC 68180-422-01 D-0517-2019
Class III · Low risk

Lovastatin Tablets USP

CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.

Terminated Impurity / degradation American Health Packaging NDC 68001-316-00 D-1584-2019
Class III · Low risk

Lovastatin Tablets USP

CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.

Terminated Impurity / degradation Lupin Pharmaceuticals Inc. NDC 68180-469-07 D-0513-2019
Class III · Low risk

Ciclopirox shampoo 1%

Failed Degradation/Impurities Specifications: Out of specification related substance results during stability testing.

Terminated Impurity / degradation Perrigo New York, Inc. D-0512-2019
Class III · Low risk

Mometasone Furoate Cream

Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.

Terminated Labeling / mix-up ACP Nimble Buyer, Inc. NDC 0713-0726-37 D-0514-2019
Class III · Low risk

Moxifloxacin Ophthalmic Solution USP

Failed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained.

Terminated Impurity / degradation Lupin Pharmaceuticals Inc. NDC 68180-422-01 D-0484-2019
Class III · Low risk

Diltiazem HCl CD capsules

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 68682-521-01 D-0491-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0798-30 D-0490-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0797-30 D-0489-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0796-30 D-0488-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0795-30 D-0487-2019

Recalls by year